Navigation Links
InsiteResearch Market Momentum Continues to Accelerate
Date:9/14/2009

BRIDGEWATER, N.J., Sept. 14 /PRNewswire/ -- InsiteResearch, LLC, a leading provider of Key Opinion Leader (KOL) relationship management, identification, influence mapping and automated data services to the life sciences industry, is gaining momentum in its impact to support expanding customer needs to most effectively interact with physicians. Eric Johnson, senior vice president and general manager, InsiteResearch, will address two upcoming major industry conferences as a lead speaker. Furthermore, InsiteResearch was recently covered in the Gartner report, "Key Opinion Leader Management in Life Sciences: Utilizing the Peer Channel to Educate and Inform Physicians" by Dale Hagemayer.

Johnson will be a presenter at the ExL Pharma 5th Annual Medical Science Liaison Best Practices Conference to be held September 16-17, 2009 at the Omni San Diego, California. Johnson's address will include strategies to optimize Key Opinion Leader identification for information dissemination and education. Johnson will also explore the impact of the Physician Sunshine Payment Act on Key Opinion Leader segmentation.

Later this year, Johnson will be a key presenter at CBI's 6th Annual Conference, "Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders," to be held November 9-10, 2009 at the Princeton, NJ Hyatt Regency. He will discuss trends and best practices for Key Opinion Leader relationship management.

"We are proud of Insite's capabilities to support their clients with service and innovative technology, which makes them important partners in the pharmaceuticals industry," said Jeff Brady, president, Advanced Health Media, parent company of InsiteResearch.

The Gartner report, published on June 15, 2009, is available to Gartner clients at www.gartner.com.

About InsiteResearch, LLC

InsiteResearch, LLC, a division of Advanced Health Media, LLC is a Pharmaceutical and Biotech industry leader in providing customized and comprehensive solutions for Key Opinion Leader (KOL) identification, influence mapping, secondary/primary market research, automated data services and enterprise wide relationship management. Today, many leading global companies rely on InsiteResearch's proprietary technology solutions: The Keystone(TM) of KOL Management, InsiteNow(TM) KOL Data Services and IM2(TM) KOL Mapping to build more effective relationships with KOLs. For more information, please see the InsiteResearch website at www.insiteresearch.net.

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM has developed and markets a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management, and compliance tracking and reporting systems. AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, N.J., and with offices in Union and Somerville, N.J. and Chesapeake, Va., AHM is the parent company of AHM Solutions; Centeon Solutions; Embryon, LLC; Cogenix, LLC; ProMedix, LLC; and InsiteResearch, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.


'/>"/>
SOURCE InsiteResearch, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
3. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
4. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
5. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
6. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
7. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Dental Implant Market Insights Webinar
10. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
11. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):